作者的详细信息

Криворотько, П. В

期 栏目 标题 文件
编号 1S (2009) Articles ANTIANGIOGENNYE PREPARATY V LEChENII RAKA MOLOChNOY ZhELEZY
编号 18 (2012) Articles A new approach to the overcoming resistance to hormone therapy of breast cancer
编号 17 (2013) Articles Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
编号 8 (2016) Articles NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
编号 17 (2016) Articles TAXANES IN THE TREATMENT OF BREAST CANCER
编号 17 (2017) Articles New possibilities of the treatment of breast cancer: microtubule inhibitors
编号 7 (2018) Articles GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
编号 12 (2018) Articles Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
卷 27, 编号 7 (2020) Articles Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
卷 27, 编号 7 (2020) Articles Treatment of residual breast cancer
卷 27, 编号 7 (2020) Articles Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
卷 29, 编号 7 (2022) Articles Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
卷 29, 编号 7 (2022) Articles Treatment of HER2-positive early (minimal) breast cancer
卷 29, 编号 11/12 (2022) Articles The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
卷 29, 编号 11/12 (2022) Articles Ixabepilone in the treatment of breast cancer
##common.cookie##